深潮 TechFlow
vip
TechFlow News, on November 21, Enlivex Therapeutics, an Israeli clinical-stage immunotherapy company, announced that its board approved the use of up to $1 million to purchase Bitcoin as part of its cash management strategy.

The company is listed on Nasdaq in the United States (code: ENLV), CEO Oren Hershkovitz said that with the rise in demand and acceptance of Bitcoin, coupled with the recent approval of Bitcoin ETFs and support from institutional investors, the company believes that Bitcoin can serve as a strong asset reserve, providing value storage and inflation resistance.
View Original
  • Reward
  • Comment
  • Share
Comment
No comments